Thursday, August 07, 2014 8:33:17 PM
Also wanted to add that we are anticipating news on plans for a Phase 2 trial of MST 188 in Heart Failure. Non clinical results from earlier this year were very positive and May's Q-10 gives an early 2015 tentative date for the initiation of this promising trial.
We are also anticipating progress of the development of MST188 in resuscitation from shock/major trauma in collaboration with the Department of Defense.
Again, plenty of information available if you enjoy digging through their sec filings. Their next Q-10 is due very soon. I expected it on 8/4, but now it looks like Monday 8/11 is the next logical release date looking at past practice.
RR
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM